Previous Page  1837 / 1840 Next Page
Information
Show Menu
Previous Page 1837 / 1840 Next Page
Page Background

Improvement in Chemoradiation

Without Brachytherapy

366 resectable tumors (T2-3N0-1M0)

Randomization RT vs. CRT followed by resection

41.4 Gy (1.8) + paclitaxel 50 mg/m2

+ carboplatin AUC = 2 mg/ml/min

92% R0 resections

Pathologic CR 29%

Median Survival:

RT 24 mths vs. CRT 49.4 mths.

3 y OS:

RT 44% vs. CRT 58%

Van Hagen, New Engl J Med 2012;366:2074-2084